Hold on tight: COVID-19 vaccine may just be a couple of months away
New York: Moderna Inc and Pfizer Inc have launched two 30,000-subject trials of COVID-19 vaccines. These trials could clear the ...
Read moreNew York: Moderna Inc and Pfizer Inc have launched two 30,000-subject trials of COVID-19 vaccines. These trials could clear the ...
Read moreNew Delhi: Five sites across the country are ready for the third and final phase of human trials of the ...
Read moreBhubaneswar: The human clinical trial of indigenously developed ‘Covaxin’, a possible vaccine against the novel coronavirus, began at an institute ...
Read moreNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read moreNew Delhi: The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at the AIIMS ...
Read moreSingapore: Scientists have developed a rapid test to detect antibodies in COVID-19 patients that specifically block the novel coronavirus. It ...
Read moreNew York: Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses ...
Read moreChicago: Early data from trials of three potential COVID-19 vaccines released Monday increased confidence that a vaccine can train the ...
Read moreLondon: The initial trial data for the COVID-19 vaccine which has been developed in a joint collaboration between Oxford University ...
Read moreDhaka: Bangladesh’s state medical research agency has approved a third-phase trial of a potential COVID-19 vaccine. The COVID-19 vaccine has ...
Read more